Does Sepsis Keep Killing Months Later?

Researchers set out to discover if the risk of death from sepsis continues even after the acute infection has been cured.

8:00 AM

Author | Kylie Urban

It's known that many patients die in the months and years after sepsis.

But no one has known if this increased risk of death (in the 30 days to 2 years after sepsis) is because of sepsis itself, or because of the pre-existing health conditions the patient had before acquiring the complication. After all, patients with more medical problems are more likely to develop sepsis.

In a new study published in BMJ, Hallie Prescott, M.D. MSc., assistant professor of internal medicine at the University of Michigan Health System, investigated the phenomenon.

"We know sicker patients are more likely to develop sepsis," says Prescott, who is a member of U-M's Institute for Healthcare Policy and Innovation. "And that made us wonder: Perhaps those previous health conditions are driving the risk of late death after sepsis?" Late death refers to the deaths that take place months to years after the acute infection has resolved.

Sepsis is a complication of infection. The body releases chemicals in the bloodstream to help fight off infection, but sometimes those chemicals can damage the body, leading to organ failure and a dramatic drop in blood pressure. Sepsis is treated with antibiotics and fluids.

Prescott and the research team examined detailed survey data and medical records of participants in the University of Michigan's Health and Retirement Study (HRS), a national cohort of more than 30,000 older Americans. The study is supported by the National Institute on Aging and the Social Security Administration.

"To answer our question, we had to compare patients who were indistinguishable before they developed sepsis. We used the pre-existing data from the HRS to compare patients with sepsis to patients who were otherwise indistinguishable, but weren't currently hospitalized," Prescott says.

"But we also wanted to know the effect of sepsis relative to patients' hospitalization with infection and inflammation — the two cardinal features of sepsis — so we also matched the sepsis patients separately with two other groups: patients hospitalized with a non-sepsis infection and patients hospitalized with a sterile inflammatory condition, such as trauma."

This is an exciting finding because it suggests that a person's pre-existing health conditions do not explain the late death after sepsis.
Hallie Prescott, M.D.

Examining pre-sepsis health

By matching the patients on their likelihood of developing sepsis, the research team ensured their final study groups was indistinguishable in terms of age, gender, health status and other diseases, among other characteristics.

Prescott and team then analyzed the late death rates and found that among the patients who survived for 30 days after their sepsis hospitalization, 40 percent died within the next two years.

"It was interesting because this high rate of late mortality was not explained by the patient's age, socio-demographics or their pre-sepsis health status," Prescott says.

"Rather, we found that, compared to the group of adults not in the hospital, one in five patients who survived sepsis had a late death that was not explained by their baseline characteristics. Compared to the patients admitted to the hospital with a non-sepsis infection or sterile inflammatory condition, patients with sepsis had a 10 percent and 16 percent absolute increase in late death, respectively."

She adds, "This is an exciting finding because it suggests that a person's pre-existing health conditions do not explain the high rate of late death after sepsis. This means that the late deaths after sepsis may be more amenable to treatment than we previously thought."

Prescott mentions this is just the beginning in further sepsis research.

"We need to understand the underlying biological processes that cause this late mortality in patients."


More Articles About: Rounds Sepsis infectious disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Enlargement of microscopic HIV virus cells
Health Lab
Researchers open new leads in anti-HIV drug development, using compound found in nature
Researchers open new leads in anti-HIV drug development, using a compound found in nature
Pink, blue, purple illustration of COVID-19 virus
Health Lab
Four years later, what do we know about COVID-19?
Today, thanks to researchers, medical and public health experts, pharmaceutical companies, engineers and others, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before.
Illustration of scientists and doctors playing basketball in white coats and scrubs
News Release
Four U-M teams selected for virtual tournament of science
U-M researchers' work made the bracket in the 2024 STAT Madness tournament of science, and need public support to advance
Health care provider loads syringe with measles vaccine
Health Lab
Measles: 10 things to know about immunization and prevention
Measles: 10 things to know about immunization and prevention
colorful illustration with human figure and highlighted lungs
Health Lab
Multimodal AI model may guide personalized treatments for tuberculosis
AI approach helps researchers interpret large biomedical data sets to accurately predict tuberculosis treatment prognosis
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants